Return to study ST001251 main page
MB Sample ID: SA091144
Local Sample ID: | 17_21 _t_60 |
Subject ID: | SU001319 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Age Or Age Range: | 19-27 |
Weight Or Weight Range: | 58-92 |
Height Or Height Range: | 172-190 |
Gender: | Male |
Human Race: | Caucasian |
Human Trial Type: | Prospective randomized open label controlled intervention study |
Human Medications: | None |
Human Prescription Otc: | None |
Human Smoking Status: | Non smoker |
Human Alcohol Drug Use: | Not in |
Human Nutrition: | Fasted for 12 hours before the first sample was obtained. |
Human Inclusion Criteria: | Healthy (normal physical examination, electrocardiography, and routine laboratory values). |
Human Exclusion Criteria: | Febrile illness during the 2 weeks before the endotoxemia experiment, taking any prescription medication, history of spontaneous vagal collapse, practicing or experience with any kind of meditation, or participation in a previous trial where LPS was administered. |
Select appropriate tab below to view additional metadata details:
Combined analysis:
Analysis ID | AN002077 |
---|---|
Analysis type | MS |
Chromatography type | Reversed phase |
Chromatography system | Agilent 1290 |
Column | Discovery HS F5-3 (15cm x 2.1 mm,3um) Supelco,Sigma Aldrich) |
MS Type | ESI |
MS instrument type | QTOF |
MS instrument name | Agilent 6540 QTOF |
Ion Mode | UNSPECIFIED |
Units | relative abundance |